HIV infection, through the actions of viral accessory protein Nef, impairs activity of cholesterol transporter ABCA1 inhibiting cholesterol efflux from macrophages and elevating the risk of atherosclerosis. Nef also induces lipid raft formation. In this study, we demonstrate that these activities are tightly linked and affect macrophage function and HIV replication. Nef stimulated lipid raft formation in macrophage cell line RAW 264.7, and lipid rafts were also mobilized in HIV-1-infected human monocyte-derived macrophages. Nef- 
Nef exerts pleiotropic effects during viral infection, and although Nef expression is not strictly essential for viral replication in vitro, it significantly enhances infectivity of nascent virions (7) . One mechanism by which Nef controls viral infectivity is through increasing cholesterol content of lipid rafts (8). Nef induces a number of genes involved in cholesterol synthesis (8, 9) and can facilitate cholesterol delivery to lipid rafts (8, 10) . This activity is consistent with membrane localization of Nef due to myristoylation (8, 11, 12) , and nonmyristoylated Nef did not affect lipid rafts (8). Lipid rafts are the preferential sites of HIV-1 assembly and budding, and cholesterol content of lipid rafts determines the cholesterol content of virions, which is critical for virion infectivity. Cholesterol depletion of HIVinfected cells reduces infectivity of released virions, which was shown to correlate with the amount of virion-associated cholesterol and the activity of Nef (6, 13) . In addition, depletion of cellular cholesterol, which reduces the abundance of rafts, also reduces HIV-1 particle production (6, 10) . Therefore, primary cholesterol-related activity of Nef may be to increase
Isolation of apoA-I
High density lipoprotein (1.083<d<1.21 g/L) was isolated by sequential centrifugation in KBr solutions, delipidated, and apoA-I was purified by gel filtration chromatography as previously described (17) .
siRNA experiments
Cells were treated with TO-901317 (0.5 µM) for 18 hours, and transfected with ABCA1-or Nef-specific siRNA or scrambled siRNA (control) using Lipofectamine 2000 TM (Invitrogen). ABCA1 siRNA and scrambled siRNA were from Ambion. Nef siRNA was custom-designed and manufactured by Invitrogen.
Analysis of HIV-1 infectivity
Monocyte-derived macrophages were infected with HIV-1 ADA and were maintained for 10 days until infection reached the plateau (5x10 3 cpm/ml of RT activity). Cells were transfected with ABCA1-targeting or control siRNA twice with a 24 h interval, washed, and cultured for 2 days after the second transfection. Virus was collected from the supernatant, concentrated, adjusted according to p24 content and used to infect indicator TZM-bl cells (18) . 48 h after infection, luciferase activity was measured on Perkin Elmer luminescence counter.
Lipid raft cholesterol content analysis
To assess the transfer of cholesterol to lipid rafts we used three approaches. The first approach utilized a selective binding of cholera toxin subunit B (CT-B) to GM1, a marker of rafts. The cells were treated with 0. were obtained using TCS SP5 2-photon microscope (Leica) microscope equipped with photomultiplier tubes and acquisition software (Leica). Laurdan dye was excited at 800 nm with a 2-photon laser (Mai-Tai HP, Spectra-Physics), and emission intensities were recorded simultaneously in the ranges of 400-460 nm and 470-530 nm. Laurdan dye intensity images for each pixel were converted into GP (generalized polarization) images using custom-made algorithm. The GP is defined as: GP= (I (400-460) -I (470-530) / (I (400-460) +I ) where I is the emission intensity. GP distributions were obtained from the histograms of the GP images, normalized (sum = 100) and fitted to Gaussian distributions using nonlinear fitting algorithm.
Cell fractionation
To isolate the membrane fraction, RAW 264.7 and N7 cells were washed with cold PBS, re-suspended in 5 mM Tris buffer, incubated for 30 min at 4 o C and freeze-thawed twice. Debris was removed by low-speed centrifugation and supernatant was subjected to centrifugation at 100,000 x g for 1 h at 4 o C. Pellet was resuspended in buffer containing 50 mM Tris, protease and phosphatase inhibitors cocktail (Roche), 2 mM β-mercaptoethanol and 1% Triton X-100. Images were taken by sequential line acquisition.
Quantitative co-localization was assessed using Volocity software (Perkin-Elmer).
For co-localization the images were first subjected to intensity threshold to eliminate the dark current registered at the image, followed by extracting the product of the differences from the mean (PDM). Positive PDM was determined for a single cell, where pixel intensities of GFP and RFP are varying synchronously and more positive PDM indicates a stronger degree of co-localization. We used the positive PDM as indicator for co-localizing pixels, since by definition these pixels represent higher than the main pixel value (over threshold) for both channels and reduce the probability of including adjacent structures in the co-localization outcome. This protocol was applied to 10 cells per sample.
Cholesterol efflux
Cholesterol efflux was measured as described previously (20) . Briefly, cells were incubated in serum-containing medium supplemented with [ 
Cholesteryl ester biosynthesis
Cells were incubated for 18 h in serum-containing medium in the presence of 50 μg/ml of acetylated LDL (AcLDL). Cholesteryl ester biosynthesis was then assessed by incorporation of [ 14 C]oleic acid into cholesteryl esters over 2 h as described previously (3).
MTT assay -One hundred µl of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added per 500 µl cell culture media, and cultures were incubated at Unless indicated otherwise, means ± SEM of quadruplicate determinations are presented.
RESULTS
In this study, we used mouse macrophage cell line N7, which is derived from RAW 264.7 cells and is stably transfected with HIV-1 Nef under Cd-activated promoter (14) . This cell line was used because it is the only available cell line stably transfected with Nef under control of a regulated promoter, and parent RAW 264.7 cells were previously used to study the effects of Nef ( 
Nef stimulates formation of lipid rafts
There is no commonly accepted approach to evaluate the amount of cholesterol in rafts and/or abundance of rafts; therefore, we used three independent methods to assess the effect of Nef on the abundance of lipid rafts. First, we used flow cytometry to assess binding to cells of cholera toxin subunit B, which binds specifically to the accepted marker of rafts, GM1. Results of these experiments are presented in Fig 
Inhibition of ABCA1 stimulates Nef-dependent formation of rafts
Given that Nef inhibits ABCA1-dependent cholesterol efflux while increasing the abundance of cholesterol in rafts, we investigated if these two cholesterol trafficking pathways (Nef-dependent and ABCA1-dependent) are connected. One possibility was that Nef "hijacks" ABCA1 and uses the ABCA1-dependent pathway to transfer cholesterol to rafts, instead of transferring it to an extracellular acceptor. Alternatively, Nef may compete with ABCA1 for cholesterol. To distinguish between these two possibilities, we inhibited ABCA1-dependent cholesterol trafficking and investigated the effect of this inhibition on
Nef-dependent trafficking of cholesterol to rafts. We expected that if ABCA1 is critical to Nef-dependent cholesterol trafficking, inhibition of ABCA1 would also inhibit Nefdependent cholesterol delivery to lipid rafts. (Fig. 3A) . Consistent with our previous report showing suppression of cholesterol efflux by Nef (3), the efflux from N7 cells was about half of that from RAW 264.7 cells (Fig. 3B) . Only BLT1 caused a small further inhibition of cholesterol efflux, presumably through cross-inhibition of SR-B1-dependent efflux (25). Abundance of rafts in this experiment was assessed using the cholesterol oxidase method. BLT compounds did not have a statistically significant effect on the abundance of rafts in RAW 264.7 cells (Fig. 3C ). However, in N7 cells BLT compounds significantly increased the abundance of rafts (Fig. 3D) . Similar results were obtained using the CT-B binding method of lipid raft analysis (Supplemental Fig. I ). These findings indicate that inhibition of ABCA1 function without altering its abundance is sufficient to enhance effects of Nef.
Next, we used siRNA to knock-down ABCA1 in RAW 264.7 and N7 cells. In both cell types approximately 80% knockdown efficiency was achieved (Fig. 3E ) resulting in an almost complete elimination of specific cholesterol efflux to apoA-I (not shown). When the abundance of rafts was assessed by cholesterol oxidase susceptibility, knockdown of ABCA1 caused a statistically significant increase of lipid rafts in both RAW 264.7 and N7 cells, however, the magnitude of the effect was much greater in N7 cells activated with CdCl 2 (Fig.   3F ). When lipid raft abundance was assessed by CT-B binding, knockdown of ABCA1 did not affect abundance of rafts in RAW 264.7 cells, but caused a statistically significant increase in raft abundance in N7 cells (Fig. 3G ). Rather, Nef-dependent inhibition of ABCA1 may contribute to raft modulation.
Nef reduces ABCA1 stability and promotes its re-localization away from the cell surface
To better understand the Nef-dependent inhibition of ABCA1, we next analyzed the (lane 6 versus 4). These differences were not due to differences in ABCA1 expression as the abundance of ABCA1 mRNA was not affected by Nef (Fig. 4B) . Thus, Nef may increase degradation of ABCA1.
We assumed that the impairment of ABCA1 functionality and turnover by Nef may be related to changes in the sub-cellular localization of ABCA1. We first hypothesized that, analogous to its effect on cholesterol distribution, Nef may also facilitate ABCA1 transfer to rafts, as Nef is known to transfer a number of proteins to lipid rafts (27, 28). Such redistribution of ABCA1 from its usual non-raft location (29) may cause its dysfunction and instability. To test this hypothesis, we isolated raft and non-raft fractions of the plasma membrane and analyzed them for ABCA1. The abundance of ABCA1 in the raft fraction of N7 cells was 27% lower and in the non-raft fraction was 38% higher than that in RAW 264.7 cells (Fig. 4C) . Thus, Nef did not increase the abundance of ABCA1 in rafts. Further, we assessed the accessibility of ABCA1 to biotinylation, which shows the level of ABCA1 exposure on the cell surface. The abundance of biotinylated ABCA1 in N7 cells was approximately 3 times lower than that in RAW 264.7 cells (Fig. 4D ) despite similar levels of total ABCA1 (Fig. 4A) . We therefore conclude that ABCA1 in Nef-expressing cells is not re-localized to the raft fraction but becomes less exposed at the cell surface, providing a possible explanation for impaired functionality and/or increased turnover of ABCA1.
Nef induces degradation of ABCA1 in lysosomes
To further investigate the interaction of Nef and ABCA1, we employed another model, To assess the effect of Nef on ABCA1 distribution, HeLa-ABCA1 cells transiently transfected with Nef or an empty vector were treated with biotin, lysed, and passed through an anti-biotin column; both bound and unbound fractions were analyzed by Western blot.
The bound fraction represents ABCA1 exposed at the cell surface, while the unbound fraction represents ABCA1 in a mixture of membranes, mainly intracellular, but also the inner leaflets of the plasma membrane. The overall abundance of ABCA1 in cells transfected with Nef was less than half compared to mock transfected HeLa-ABCA1 cells. While the abundance of both cell surface and intracellular ABCA1 was decreased, the effect of Nef on intracellular ABCA1 was greater (Fig. 5A) . Consequently the ratio of cell surface/intracellular ABCA1 in Nef-transfected cells was 1.5 fold higher than in mock transfected cells (Fig. 5B) , despite an overall lower amount of cell surface ABCA1.
The same model, HeLa-ABCA1 cells, was used to further investigate the mechanisms of Nef-induced redistribution of ABCA1. Nef has been shown to re-route proteins such as CD4 to lysosomes for degradation (30). We hypothesized that the same mechanism may be responsible for reduction of intracellular ABCA1 by Nef, while ABCA1 on the plasma membrane would be less susceptible. To investigate this possibility, we examined the co- The increased co-localization of ABCA1 and LAMP-1 in the presence of Nef suggests that Nef may stimulate ABCA1 degradation via the lysosomal pathway. We tested this hypothesis by examining the effect of a lysosomal inhibitor, chloroquine, on Nef-mediated ABCA1 degradation. Nef-or mock-transfected HeLa-ABCA1-GFP cells were treated with chloroquine for 48 h and abundance of ABCA1 was examined by Western blot (Figs. 6A, B) .
Inhibition of lysosomal activity prevented Nef-mediated reduction of ABCA1 protein abundance. Thus, Nef mediated reduction of ABCA1 abundance depends, at least partially, on a lysosomal degradation pathway. This was further confirmed when the effect of chloroquine on cholesterol efflux was studied. When Nef or mock-transfected HeLa-ABCA1 cells were treated with chloroquine, Nef-mediated inhibition of ABCA1-specific efflux was reversed (Fig. 6C) .
The effect of Nef on macrophage functions
Inhibition of ABCA1 activity and increased abundance of lipid rafts in Nefexpressing cells may have significant effects on macrophage immune functions (31). To investigate this possibility, we first assessed the effect of Nef on endocytosis. Using GFPconjugated CT-B, which binds to lipid raft-associated GM1, we found increased CT-B binding to N7 cells versus RAW 264.7 macrophages (Fig. 7A) . This is consistent with Nefmediated increase of lipid raft abundance. However, internalization of bound CT-B was much less efficient in N7 than in RAW 264.7 cells: whereas mean fluorescence intensity increased 5.6-fold when RAW 264.7 cells were incubated at 37 o C instead of 4 o C, in N7 cells the increase was only 1.2-fold. A similar outcome was observed when another function of macrophages, phagocytosis, was analyzed using particles with pH-sensitive fluorescent dye pHrodo. Both lipopolysaccharide (LPS)-stimulated ( Fig. 7B ) and un-stimulated (Fig. 7C) phagocytosis was severely impaired in N7 cells as compared to RAW 264.7 cells.
Furthermore, treatment of N7 cells with Nef siRNA restored the level of LPS-stimulated phagocytosis in these cells to that in RAW 264.7 cells (Fig. 7B) . Therefore, Nef inhibits endocytic and phagocytic functions of macrophages.
HIV-1 infectivity negatively correlates with ABCA1 expression in host cell
We have previously demonstrated that pharmacological stimulation of ABCA1 expression inhibits HIV-1 infectivity by depleting viral cholesterol (6) . An intriguing consequence of this finding is that HIV infectivity may be influenced by the level of ABCA1 abundance in infected cells. To investigate this possibility, we compared HIV infectivity in two human cell types that are the primary targets of natural HIV-1 infection, macrophages and T lymphocytes. Monocyte-derived macrophages (MDM) have high abundance of ABCA1 which was readily activated by an LXR agonist TO-901317 (Fig. 8A) . Peripheral blood leukocytes (PBL) have undetectable levels of ABCA1 under basal conditions, but ABCA1 expression in these cells can be up-regulated with the LXR agonist. Consistent with our expectations, infectivity of HIV-1 produced by "high ABCA1" cell type, MDM, was about 30% of that of virus produced by "low ABCA1" cell type, PBL (Fig. 8B ). This difference was eliminated when ABCA1 in MDM was suppressed by siRNA (Fig. 8B) .
Thus, high expression of ABCA1 in host cells is detrimental for HIV-1 infectivity.
DISCUSSION
In this study we investigated the interaction between viral and host pathways of To distinguish between these two possibilities we investigated whether inhibition of the ABCA1-dependent pathway would affect Nef-dependent cholesterol trafficking to rafts. We expected that if ABCA1 is hijacked by the Nef-dependent pathway, functional and physical inhibition of ABCA1 would inhibit Nef-mediated cholesterol delivery to rafts. Contrary to these expectations, we observed a stimulation of Nef-dependent trafficking of cholesterol to rafts after reducing ABCA1 levels or after inhibiting ABCA1-dependent cholesterol trafficking. Combined with the observation that pharmacological stimulation of ABCA1 expression inhibits HIV infectivity (6), these findings suggest that HIV does not utilize ABCA1 to transfer cholesterol to rafts, but rather the two pathways compete with each other.
We used two cellular models to investigate the mechanisms of ABCA1 inhibition by The mechanism of endocytosis and phagocytosis impairment in our model is unclear, but it is Nef-mediated and may be related to the effects of Nef on trafficking of membrane-bound proteins to and from rafts (38) .
Our finding that infectivity of HIV-1 virions produced by lymphocytes is much higher than infectivity of virions released by MDM, and that this difference is eliminated when ABCA1 expression in MDM is knocked down by siRNA, is consistent with our previous report that ABCA1 inhibits HIV-1 infectivity via decreasing cholesterol in lipid rafts and thus limiting cholesterol incorporated into nascent HIV virions (6) . However, this is the first demonstration that such activity may have implications for HIV-1 replication in natural target cells. Higher infectivity of virions produced from cells with low ABCA1 expression, such as non-activated T lymphocytes or undifferentiated monocytes, may partially compensate for lower virus production by these cells.
Taken together, results of this study demonstrate that Nef triggers a re-localization of ABCA1 making it less accessible at the cell surface and more susceptible to degradation, resulting in an inhibition of cholesterol efflux and increased abundance of lipid rafts. We propose the following model of this phenomenon (Fig. 9) . Under normal circumstances, ABCA1 re-circulates between plasma membrane, where it is located in non-raft compartments, and intracellular compartments, mainly early endosomes, late endocytic vesicles, and lysosomes (16) (Fig. 9A) . Nef may affect re-circulation by directly or indirectly preventing ABCA1 from returning to the cell surface, instead re-directing it to lysosomes; reduced ABCA1 abundance on plasma membrane promotes formation of more rafts. On the other hand, Nef by itself may stimulate formation of rafts reducing abundance of non-raft compartment suitable for ABCA1, shifting a balance between plasma membrane and intracellular ABCA1 toward the latter. However, ABCA1 does not accumulate in the intracellular compartments; instead, with possible assistance of Nef, the flow of ABCA1
shifts toward lysosomes causing rapid degradation of ABCA1 (Fig. 9 B) . Preventing degradation of ABCA1 in the lysosomes apparently shifts the balance back toward the plasma membrane. The result of this activity is two-fold: it promotes viral assembly and infectivity, and it affects functional capacity of targeted cells, in particular macrophages.
This study implicates ABCA1 as a key molecule targeted by HIV to facilitate viral propagation at the same time disabling cellular defences, and underscores the role of ABCA1
as an innate anti-HIV factor. The mechanisms described in this study may not be unique for HIV and may be used by other microorganisms whose life cycles depend upon raft cholesterol to achieve the same outcome. GAPDH is shown as loading control. by guest, on August 15, 2017 www.jlr.org
